BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 11084647)

  • 1. Cranial sutures as intramembranous bone growth sites.
    Opperman LA
    Dev Dyn; 2000 Dec; 219(4):472-85. PubMed ID: 11084647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis.
    Opperman LA; Adab K; Gakunga PT
    Dev Dyn; 2000 Oct; 219(2):237-47. PubMed ID: 11002343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cranial suture morphogenesis.
    Ogle RC; Tholpady SS; McGlynn KA; Ogle RA
    Cells Tissues Organs; 2004; 176(1-3):54-66. PubMed ID: 14745235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dura mater maintains rat cranial sutures in vitro by regulating suture cell proliferation and collagen production.
    Opperman LA; Chhabra A; Nolen AA; Bao Y; Ogle RC
    J Craniofac Genet Dev Biol; 1998; 18(3):150-8. PubMed ID: 9785219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency.
    Greenwald JA; Mehrara BJ; Spector JA; Warren SM; Crisera FE; Fagenholz PJ; Bouletreau PJ; Longaker MT
    J Bone Miner Res; 2000 Dec; 15(12):2413-30. PubMed ID: 11127206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro.
    Opperman LA; Nolen AA; Ogle RC
    J Bone Miner Res; 1997 Mar; 12(3):301-10. PubMed ID: 9076572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue interactions with underlying dura mater inhibit osseous obliteration of developing cranial sutures.
    Opperman LA; Sweeney TM; Redmon J; Persing JA; Ogle RC
    Dev Dyn; 1993 Dec; 198(4):312-22. PubMed ID: 8130378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cranial deformation in craniosynostosis. A new explanation.
    Delashaw JB; Persing JA; Jane JA
    Neurosurg Clin N Am; 1991 Jul; 2(3):611-20. PubMed ID: 1821307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development.
    Kim HJ; Rice DP; Kettunen PJ; Thesleff I
    Development; 1998 Apr; 125(7):1241-51. PubMed ID: 9477322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration in vitro.
    Opperman LA; Passarelli RW; Morgan EP; Reintjes M; Ogle RC
    J Bone Miner Res; 1995 Dec; 10(12):1978-87. PubMed ID: 8619379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta 3(Tgf-beta3) in a collagen gel delays fusion of the rat posterior interfrontal suture in vivo.
    Opperman LA; Moursi AM; Sayne JR; Wintergerst AM
    Anat Rec; 2002 Jun; 267(2):120-30. PubMed ID: 11997880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extracellular matrix environment in suture morphogenesis and growth.
    Opperman LA; Rawlins JT
    Cells Tissues Organs; 2005; 181(3-4):127-35. PubMed ID: 16612078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction of coronal suture synostosis using suture and dura mater allografts in rabbits with familial craniosynostosis.
    Mooney MP; Burrows AM; Smith TD; Losken HW; Opperman LA; Dechant J; Kreithen AM; Kapucu R; Cooper GM; Ogle RC; Siegel MI
    Cleft Palate Craniofac J; 2001 May; 38(3):206-25. PubMed ID: 11386428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal capsular cartilage is required for rat transpalatal suture morphogenesis.
    Adab K; Sayne JR; Carlson DS; Opperman LA
    Differentiation; 2003 Oct; 71(8):496-505. PubMed ID: 14641330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion.
    Roth DA; Longaker MT; McCarthy JG; Rosen DM; McMullen HF; Levine JP; Sung J; Gold LI
    J Bone Miner Res; 1997 Mar; 12(3):311-21. PubMed ID: 9076573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of Egf treatment differentially affects Tgf-beta2 induced cranial suture closure.
    Rawlins JT; Fernandez CR; Cozby ME; Opperman LA
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1518-26. PubMed ID: 18849541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta3 (Tgf-beta3) down-regulates Tgf-beta3 receptor type I (Tbetar-I) during rescue of cranial sutures from osseous obliteration.
    Opperman LA; Galanis V; Williams AR; Adab K
    Orthod Craniofac Res; 2002 Feb; 5(1):5-16. PubMed ID: 12071374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sutural biology and the correlates of craniosynostosis.
    Cohen MM
    Am J Med Genet; 1993 Oct; 47(5):581-616. PubMed ID: 8266985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cranial suture obliteration is induced by removal of transforming growth factor (TGF)-beta 3 activity and prevented by removal of TGF-beta 2 activity from fetal rat calvaria in vitro.
    Opperman LA; Chhabra A; Cho RW; Ogle RC
    J Craniofac Genet Dev Biol; 1999; 19(3):164-73. PubMed ID: 10589398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetics of craniofacial development].
    van Adrichem LN; Hoogeboom AJ; Wolvius EB
    Ned Tijdschr Tandheelkd; 2008 Feb; 115(2):61-8. PubMed ID: 18326400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.